Transferring Sutent free medicinesSutent free medicine prices

Generic name: Sunitinib malate capsules. Our company promises to be honest and sell genuine products at real prices. Cash on delivery. Inquiry phone number. Generic name: Sunitinib malate capsules. Molecular structure name. Name: Sunitinib malate. English name. Specifications: tablets/box. Usage: Daily. Tablets, take one tablet once. The drug needs to be discontinued after taking for 1 week and observed for 1 week. Continue taking the treatment for 1 week/treatment course. Indications: Gastrointestinal stromal tumor, advanced renal cell carcinoma, which has failed or cannot be tolerated by imatinib. Manufacturer: Pfizer. In addition to gastrointestinal stromal tumors and inhibiting advanced renal cell carcinoma, it is now clinically proven to treat non-small cell lung cancer and hepatocellular carcinoma. [Sutent Indications] Gastrointestinal stromal tumors that have failed or are intolerable to imatinib sulfonate. Operable advanced renal cell carcinoma. Sunitinib (Sutent) - a new drug for renal cancer, gastrointestinal stromal tumor, non-small cell lung cancer and liver cancer. Indications Multi-targeted treatment of tumors Sunitinib is a new multi-targeted oral drug for the treatment of tumors. Sunitinib is primarily being developed for the treatment of gastrointestinal stromal tumors and metastatic renal cell carcinoma that are unresponsive or intolerant to standard therapies. Sunitinib selectively targets receptors on certain proteins, which are thought to act like a molecular switch in tumor growth. The above-mentioned indications of sunitinib [Sutent usage and dosage] The recommended dose for the treatment of gastrointestinal stromal tumors and advanced renal cell carcinoma is once a day, oral administration week and drug withdrawal week (/dosing schedule). It can be taken with or without food. [Precautions for Sutent] If clinical manifestations of congestive heart failure occur, it is recommended to discontinue the drug. Patients with no clinical evidence of congestive heart failure but an ejection fraction < and an ejection fraction below baseline should also be discontinued and/or dose reduced. Sutent prolongs the interval in a dose-dependent manner. It should be used with caution in patients with a known history of interval prolongation, patients taking antiarrhythmic drugs, or patients with underlying cardiac disease bradycardia and electrolyte imbalance. If severe hypertension occurs during use, use should be suspended until the hypertension is controlled. Women of childbearing potential should use contraception while receiving Sutent. Breastfeeding women receiving Sutent should weigh the decision as to whether to discontinue breastfeeding or discontinue treatment. No differences in safety or effectiveness were found in younger versus older patients. [Sutent Properties] Capsules, the contents are ** to orange particles. [Sutent Validity Period] Months [Sutent Approval Number] Registration Certificate Number [Sutent Manufacturing Enterprise]